By Professor Andrew David Carr

Journal articles

Stewart GA; Ashton LJ; Biti RA; Ffrench FA; Bennetts BH; Newcombe NR; Benson EM; Carr AD; Cooper DA; Kaldor JM; Smith DD; Catchpole BR; Allworth A; Baker D; Batty G; Beveridge A; Bloch M; Bodsworth NJ; Clare K; Cummins E; Cunningham PH; Couldwell D; Deacon N; Doong N; Finlayson R; Furner V; Huffam SE; Kidd J; Kelly MD; Lloyd AR; Mcfarlane R; Mclean K; Mcnulty A; Mcphee D; Michelmore H; Mcmurchie M; Mutimer K; Peterson J; Price R; Quan J; Qurn J; Ree H; Robertson M; Roggensack M; Schroeder K; Spencer D; Sullivan JS; Ziegler JB, 1997, 'Increased frequency of CCR-5 delta32 heterozygotes among long-term nonprogressors with HIV infection.', AIDS, 11, pp. 1833 - 1838

Carr AD; Brown DM; Cooper DA, 1997, 'Portal vein thrombosis in patients receiving indinavir, an HIV protease inhibitor', AIDS, 11, pp. 1657 - 1658

Carr AD; Cooper DA, 1997, 'Restoration of immunity to chronic hepatitis B infection in HIV-infected patient on protease inhibitor', Lancet, pp. 995 - 996

Kelleher S; Emery S; Cunningham PH; Duncombe CJ; Carr AD; Golding H; Forde S; Hudson J; Roggensack M; Forrest BD; Cooper DA, 1997, 'Safety and immunogenicity of UBI HIV-1MN octameric V3 peptide vaccine administered by subcutaneous injection', AIDS Research and Human Retroviruses, 13, pp. 29 - 32

Imrie A; Beveridge A; Genn W; Vizzard J; Cooper DA; Catchpole BR; Baker D; Bloch M; Byrne J; Carr AD; Doong N; Duncombe CJ; Finlayson R; Kidd J; Mcfarlane R; Mcmurchie M; Mcnulty A; Pethebridge A; Quan D; Robertson M, 1997, 'Transmission of human immunodeficiency virus type-1 resistant to nevirapine and zidovudine', Journal of Infectious Diseases, 175, pp. 1502 - 1506

Carr A; Garsia R, 1996, 'How HIV leads to hypersensitivity reactions', Medical Journal of Australia, 164, pp. 227 - 229, http://dx.doi.org/10.5694/j.1326-5377.1996.tb94146.x

Carr A; Garsia R, 1996, 'Managing HIV. Part 3: Mechanisms of disease. 3.5 How HIV leads to hypersensitivity reactions.', Med J Aust, 164, pp. 227 - 229, https://www.ncbi.nlm.nih.gov/pubmed/8604194

Carr A; Boyle MJ, 1996, 'Managing HIV. Part 2: Phases of disease. 2.1 Primary HIV infection.', Med J Aust, 164, pp. 105 - 106, https://www.ncbi.nlm.nih.gov/pubmed/8569558

Carr A; Boyle MJ, 1996, 'Primary HIV infection', MEDICAL JOURNAL OF AUSTRALIA, 164, pp. 105 - 106, http://dx.doi.org/10.5694/j.1326-5377.1996.tb101365.x

Cooper DA; Merigan TC, 1996, 'Clinical treatment.', AIDS London England, 10 Suppl A, pp. S133 - S134, http://dx.doi.org/10.1097/00002030-199601001-00018

Coyle P; Carr AD; Depczynski BB; Chisholm DJ, 1996, 'Diabetes mellitus associated with pentamidine use in HIV-infected patients.', Medical Journal of Australia, 165, pp. 587 - 588, http://dx.doi.org/10.5694/j.1326-5377.1996.tb138654.x

Carr A; Roseingrave P; Fitzgerald MX, 1996, 'Factors associated with stress responses in staff caring for patients with cystic fibrosis', Irish Journal of Psychology, 17, pp. 241 - 250, http://dx.doi.org/10.1080/3033910.1996.10558105

Carr A; Boyle MJ, 1996, 'Managing HIV: 2.1 Primary HIV infection', Medical Journal of Australia, 164, pp. 105 - 106, http://dx.doi.org/10.5694/j.1326-5377.1996.tb101365.x

Carr AD; Vella S; Dejong MD; Sorice F; Imrie A; Boucher CA; Cooper DA, 1996, 'A controller trial of nevirapine plus zidovudine versis zidovudine aklone in p24 antigenaemic HIV infected patients', AIDS, 10, pp. 635 - 641

Kelleher AD; Carr AD; Zaunders J; Cooper DA, 1996, 'Alterations in the immune response of HIV-infected subjects treated with an HIV specific protease inhibitor, ritonavir', Journal of Infectious Diseases, 173, pp. 321 - 329

Carr AD; Emery S; Kelleher AD; Law MG; Cooper DA, 1996, 'CD8+ lymphocyte responses to antiretroviral therapy of HIV infection', Journal of acquired immune deficiency syndrome and human retrovirology, 13, pp. 320 - 326

Carr AD; Cooper DA, 1996, 'Current clinical experience with nevirapine for HIV infection', Advances in Experimental Medicine and Biology, pp. 299 - 304

Zhu T; Wang N; Carr AD; Nam DS; Moor-Jankowski R; Cooper DA; Ho DD, 1996, 'Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions:evidence for viral compartmentalisation and selection during sexual transmission', Journal of Virology, pp. 3098 - 3107

Carr AD; Cooper DA, 1996, 'HIV protease inhibitors', AIDS, 10, pp. 151 - 157

Imrie A; Carr A; Duncombe C; Finlayson R; Vizzard J; Law M; Kaldor J; Penny R; Cooper DA, 1996, 'Primary infection with zidovudine-resistant human immunodeficiency virus type 1 does not adversely affect outcome at 1 year. Sydney Primary HIV Infection Study Group.', J Infect Dis, 174, pp. 195 - 198, http://dx.doi.org/10.1093/infdis/174.1.195

Danner SA; Carr A; Leonard JM; Lehman LM; Gudiol F; Gonzales J; Raventos A; Rubio R; Bouza E; Pintado V; Aguado AG; Garcia de Lomas J; Delgado R; Borleffs JCC; Hsu A; Valdes JM; Boucher CAB; Cooper DA, 1995, 'A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of hiv-1 protease', New England Journal of Medicine, 333, pp. 1528 - 1534, http://dx.doi.org/10.1056/NEJM199512073332303

ZHU TF; WANG N; NAM DS; CAO YZ; CARR A; COOPER D; HO DD, 1995, 'PREFERENTIAL TRANSMISSION OF CELL-ASSOCIATED VIRUS AND EVIDENCE FOR SELECTION OF HIV-1 IN THE NEW HOST FOLLOWING SEXUAL CONTACT', JOURNAL OF CELLULAR BIOCHEMISTRY, pp. 230 - 230, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1995QT86500787&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Zhu T; Wang N; Carr A; Wolinsky S; Ho DD, 1995, 'Evidence for coinfection by multiple strains of human immunodeficiency virus type 1 subtype B in an acute seroconvertor', Journal of Virology, 69, pp. 1324 - 1327, http://dx.doi.org/10.1128/jvi.69.2.1324-1327.1995

Emery S; Carr A; Cooper DA, 1995, 'If it's the virus, why aren't we measuring it?', Medical Journal of Australia, 163, pp. 508 - 509, http://dx.doi.org/10.5694/j.1326-5377.1995.tb124712.x

Carr A; Cooper DA, 1995, 'Pathogenesis and management of HIV-associated drug hypersensitivity.', AIDS Clinical Review, pp. 65 - 97

Danner SA; Carr A; Leonard JM; Lehman LM; Gudiol F; Gonzales J; Raventos A; Rubio R; Bouza E; Pintado V; Aguado AG; Delgado R; Borleffs JCC; Hsu A; Valdes JM; Boucher CAB; Cooper DA, 1995, 'Safety, pharmacokinetics, and antiviral activity of ritonavir, an inhibitor of HIV-1 protease', JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 10, pp. 75 - 75, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1995UC13800076&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kinloch-De Loes S; Hirschel B; Hoen B; Cooper DA; Tindall B; Carr AD; Saurat JH; Clumeck N; Lazzarin A; Mathiesen L; Raffi F; Antunes F; Von Overbeck J; Luthy R; Glauser M; Hawkins D; Baumberger C; Yerly S; Perneger TV; Perrin L, 1995, 'A controlled trial of zidovudine in primary human immunodeficiency virus infection', New England Journal of Medicine, pp. 408 - 413

Zaunders J; Carr AD; Mcnally L; Penny R; Cooper DA, 1995, 'Effects of primary HIV-1 infection on subsets of CD4+ and CD8+ T lymphocytes', AIDS, pp. 561 - 566

Carr A; Gross AS; Hoskins JM; Penny R; Cooper DA, 1994, 'Acetylation phenotype and cutaneous hypersensitivity to trimethoprim-sulphamethoxazole in HIV-infected patients', AIDS, 8, pp. 333 - 337, http://dx.doi.org/10.1097/00002030-199403000-00006

Carr A; Vasak E; Munro V; Penny R; Cooper DA, 1994, 'Immunohistological assessment of cutaneous drug hypersensitivity in patients with HIV infection', Clinical and Experimental Immunology, 97, pp. 260 - 265, http://dx.doi.org/10.1111/j.1365-2249.1994.tb06078.x

Carr A; Cooper DA, 1994, 'In HIV‐infected individuals who desire combination antiviral therapy, zidovudine plus zalcitabine is preferred to zidovudine plus didanosine', Reviews in Medical Virology, 4, pp. 5 - 8, http://dx.doi.org/10.1002/rmv.1980040104

Tindall B; Carr A; Goldstein D; Penny R; Cooper DA, 1993, 'Administration of zidovudine during primary HIV-1 infection may be associated with a less vigorous immune response [1]', AIDS, 7, pp. 127 - 128, http://dx.doi.org/10.1097/00002030-199301000-00020

Carr A; Penny R; Cooper DA, 1993, 'Allergy and desensitization to zidovudine in patients with acquired immunodeficency syndrome (AIDS)', Journal of Allergy and Clinical Immunology, 91, pp. 683 - 685, http://dx.doi.org/10.1016/0091-6749(93)90276-L

Tindall B; Forde S; Carr A; Barker S; Cooper DA, 1993, 'Attitudes to euthanasia and assisted suicide in a group of homosexual men with advanced HIV disease', Journal of Acquired Immune Deficiency Syndromes, 6, pp. 1069 - 1070

Tindall B; Elford J; Sharkey T; Carr A; Kaldor J; Cooper DA, 1993, 'CD4+ lymphocytopenia in HIV-seronegative homosexual men [4]', AIDS, 7, pp. 1272 - 1273

Carr A; Swanson C; Penny R; Cooper DA, 1993, 'Clinical and laboratory markers of hypersensitivity to trimethoprim-sulfamethoxazole in patients with pneumocystis carinii pneumonia and AIDS', Journal of Infectious Diseases, 167, pp. 180 - 185, http://dx.doi.org/10.1093/infdis/167.1.180

Caumes E; Lheriteau F; Gentilini M; Carr A; Tindall B; Cooper DA, 1993, 'Cotrimoxazole prophylaxis for toxoplasmosis [3]', Annals of Internal Medicine, 118, pp. 395, http://dx.doi.org/10.7326/0003-4819-118-5-199303010-00018

Carr A; Penny R; Cooper DA, 1993, 'Efficacy and safety of rechallenge with low-dose trimethoprim-sulphamethoxazole in previously hypersensitive HIV-infected patients', AIDS, 7, pp. 65 - 71

Carr A; Tindall B; Penny R; Cooper DA, 1993, 'In vitro cytotoxicity as a marker of hypersensitivity to sulphamethoxazole in patients with HIV', Clinical and Experimental Immunology, 94, pp. 21 - 25, http://dx.doi.org/10.1111/j.1365-2249.1993.tb05971.x

Carr A; Tindall B; Penny R; Cooper DA, 1993, 'Patterns of multiple-drug hypersensitivities in HIV-infected patients [4]', AIDS, 7, pp. 1532 - 1533, http://dx.doi.org/10.1097/00002030-199311000-00023

Carr A; Penny R; Cooper DA, 1993, 'Prophylaxis of opportunistic infections in patients with HIV infection', Journal of Acquired Immune Deficiency Syndromes, 6, pp. S56 - S60

Virus I; Masur H; Feinberg J; Bozzette SA; De Gruttola V; Edlin B; Eisinger R; El-Sadr W; Ellenberg S; Feigal D; Frame P; Goldberger M; Hafner R; Hardy WD; Harrington M; Hughes W; Kerkering T; Kovacs J; Leoung G; Montaner J; Muñoz A; Phair J; Sattler F; Spector S; Allen JR; Carr A; Chaisson R; Freedberg K; McKay J; Polis M, 1993, 'Recommendations for prophylaxis against pneumocystis carinii pneumonia for persons infected with human', Journal of Acquired Immune Deficiency Syndromes, 6, pp. 46 - 55

Carr A; Loewenthal M; Cooper DA, 1993, 'Update on reverse transcriptase inhibitors in HIV disease', Israel Journal of Medical Sciences, 29, pp. 26 - 30

Carr A; Tindall B; Brew BJ; Marriott DJ; Harkness JL; Penny R; Cooper DA, 1992, 'Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS', Annals of Internal Medicine, 117, pp. 106 - 111

Carr A; Tindall B; Penny R; Cooper DA, 1992, 'Trimethoprim-sulphamethoxazole appears more effective than aerosolized pentamidine as secondary prophylaxis against Pneumocystis carinii pneumonia in patients with AIDS', AIDS, 6, pp. 165 - 171

Carr A; Cooper DA; Penny R, 1991, 'Allergic manifestations of human immunodeficiency virus (HIV) infection', Journal of Clinical Immunology, 11, pp. 55 - 64, http://dx.doi.org/10.1007/BF00917741

Carr A, 1990, 'Drug hypersensitivity', Medical Journal of Australia, 153, pp. 631, http://dx.doi.org/10.5694/j.1326-5377.1990.tb126299.x

Conference Papers

Siefried KJ; Mao L; Riches R; Kerr S; Rule J; McAllister J; de Wit J; Carr A, 2017, 'Failure of antiretroviral therapy (ART) in Australian adults is mainly due to ART toxicity', in Antiviral Therapy, International Medical Press, Milan, Italy, presented at The 19th International Workshop on Co-morbidities and Adverse Drug Reaction in HIV, Milan, Italy, 23 October 2017 - 25 October 2017, http://dx.doi.org/10.26190/unsworks/27395

Siefried KJ; Mao L; Cysique LA; Rule J; Giles ML; Smith DE; McMahon J; Read TR; Ooi C; Tee BK; Bloch M; de Wit J; Carr A, 2017, 'Polypharmacy of concomitant medications in HIV-infected Australian adults is common, and associated with adverse effects', in Antiviral Therapy, International Medical Press, Milan, Italy, presented at The 19th International Workshop on Co-morbidities and Adverse Drug Reaction in HIV, Milan, Italy, 23 October 2017 - 25 October 2017, http://dx.doi.org/10.26190/unsworks/27403

Siefried KJ; Mao L; Richardson R; Kerr S; Rule J; McAllister J; de Wit J; Carr A, 2017, 'Socioeconomic and psychosocial factors are associated with suboptimal outcomes in HIV-infected adults: a case-control analysis', in Antiviral Therapy, International Medical Press, Milan, Italy, presented at The 19th International Workshop on Co-morbidities and Adverse Drug Reaction in HIV, Milan, Italy, 23 October 2017 - 25 October 2017, http://dx.doi.org/10.26190/unsworks/27399

Back to profile page